US 12,440,527 B2
Organic sol-gel nano-composition from panax notoginseng, rutin, ginkgo biloba effective in enhancing cerebral and cardiovascular protection and method of producing thereof
Nguyen Anh Van, Hanoi (VN); Nguyen Duc Nghia, Hanoi (VN); Kieu Dinh Hung, Hanoi (VN); and Nguyen Thi Ngoc Binh, Hanoi (VN)
Assigned to Nguyen Anh Van, Hanoi (VN)
Appl. No. 17/925,366
Filed by Nguyen Anh Van, Hanoi (VN)
PCT Filed Dec. 4, 2020, PCT No. PCT/VN2020/000017
§ 371(c)(1), (2) Date Nov. 15, 2022,
PCT Pub. No. WO2021/232070, PCT Pub. Date Nov. 18, 2021.
Claims priority of application No. 1-2020-02787 (VN), filed on May 15, 2020.
Prior Publication US 2023/0338448 A1, Oct. 26, 2023
Int. Cl. A61K 36/16 (2006.01); A61K 9/1271 (2025.01); A61K 9/1277 (2025.01); A61K 31/7048 (2006.01); A61K 36/258 (2006.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61P 25/06 (2006.01); A61P 25/08 (2006.01)
CPC A61K 36/16 (2013.01) [A61K 9/1271 (2013.01); A61K 9/1277 (2013.01); A61K 31/7048 (2013.01); A61K 36/258 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61P 25/06 (2018.01); A61P 25/08 (2018.01)] 2 Claims
 
1. An organic sol-gel nano-composition for enhancing cerebral and cardiovascular protection, the nano-composition comprising:
(a) 15-30% of solid lipid nano Ginkgo biloba;
(b) 2.78% of solid lipid nano rutin;
(c) 13.89% of solid lipid nano Panax notoginseng saponins;
(d) 40-65% of soy bean oil;
(e) 1-10% of lecithin; and
(f) 0.1-5% of polyoxyethylene sorbitan monooleate.